297, Novartis Investigational vaccine — Orlando, Florida

297, Novartis Investigational vaccine is a clinical research site located in Orlando, Florida, United States 32806.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

297, Novartis Investigational vaccine has participated in 1 clinical trials.

Therapeutic areas: Influenza Virus.

Sponsors: Seqirus.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 297, Novartis Investigational vaccine?

297, Novartis Investigational vaccine has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 297, Novartis Investigational vaccine conducted?

297, Novartis Investigational vaccine has 1 clinical trials on record. Their work covers Influenza Virus.

Is 297, Novartis Investigational vaccine accredited by Crixeo Health?

297, Novartis Investigational vaccine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 297, Novartis Investigational vaccine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.